Cyclooxygenase Inhibitors: all 2,871 studies that test it

Page 28 of 29. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.

• A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerStatus unknownNCT00218205Phase 2
• Ibuprofen and Renal Function in Premature InfantsCompletedNCT00217191Phase 4
• A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerStatus unknownNCT00215345Phase 2
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2
• Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC PatientsSuspendedNCT00211952Phase 3
• An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the KneeCompletedNCT00211549Phase 2
• Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and HeadCompletedNCT00204542Phase 4
• Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced WalkCompletedNCT00194090Phase 4
• Gemcitabine With Curcumin for Pancreatic CancerCompletedNCT00192842Phase 2
• STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary SurgeryCompletedNCT00190307Phase 4
• Celebrex With Preoperative Chemoradiation - Rectal CancerCompletedNCT00188565Phase 1/2
• Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus ArteriosusCompletedNCT00187447Phase 2
• A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal CancerTerminatedNCT00183807Phase 2
• Pharmacokinetics of Curcumin in Healthy VolunteersCompletedNCT00181662Not applicable
• Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLCCompletedNCT00181532Phase 2
• Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic CancerTerminatedNCT00177853Phase 1
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCompletedNCT00175032Phase 3
• The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental StressStatus unknownNCT00174902Phase 1/2
• Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The HipCompletedNCT00174317Phase 4
• Efficacy and Safety of Diclofenac Sodium Gel in Hand OsteoarthritisCompletedNCT00171652Phase 3
• Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal PainCompletedNCT00170898Phase 4
• 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid ArthritisCompletedNCT00170872Phase 3
• Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of GoutCompletedNCT00170781Phase 4
• Treatment of Fever Due to Malaria With IbuprofenCompletedNCT00167713Phase 4
• Exisulind Versus Placebo After Surgical Removal of the ProstateCompletedNCT00166426Phase 2
• A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
• Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled TrialStatus unknownNCT00165048Phase 3
• Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled TrialStatus unknownNCT00164892Phase 3
• A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's DiseaseCompletedNCT00164749Phase 1/2
• Effect Of Celecoxib On Hip Osteoarthritis (OA) ProgressionTerminatedNCT00163241Phase 3
• Use of Ketorolac in Management of Post-Operative Pain After Heart SurgeryCompletedNCT00161577Phase 4
• A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)CompletedNCT00157872Phase 4
• Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyTerminatedNCT00157508Phase 2
• Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip OsteoarthritisCompletedNCT00154219Phase 3
• Intravenous Pantoloc In Aspirin-Induced Ulcer BleedingCompletedNCT00153725Not applicable
• Effect of Selective COX-2 Inhibition on Ulcer HealingCompletedNCT00153673Phase 3
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis PatientsCompletedNCT00153660Phase 3
• Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate BrachytherapyCompletedNCT00152919Phase 3
• Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the CervixCompletedNCT00152828Phase 1/2
• Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological SurgeryCompletedNCT00150280Phase 3
• Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 SubstudyTerminatedNCT00147355Phase 3
• Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative IbuprofenCompletedNCT00145730Phase 4
• 52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or SpineCompletedNCT00145301Phase 3
• Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In JapanCompletedNCT00141154Phase 3
• A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)CompletedNCT00140972Phase 4
• A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff SyndromeTerminatedNCT00140933Phase 3
• Parecoxib in Renal ColicTerminatedNCT00139646Phase 3
• Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerCompletedNCT00137852Phase 2
• Celebrex Short Versus Long Therapy In Osteoarthritis Of The KneeCompletedNCT00137410Phase 3
• Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy PopulationCompletedNCT00137033Phase 4
• Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate CancerCompletedNCT00136487Phase 2/3
• Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast CancerCompletedNCT00135018Phase 2
• Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant PatientsCompletedNCT00129038Phase 4
• Perioperative Inflammation and Cyclooxygenase 2 (COX-2)CompletedNCT00122096Phase 4
• Magnesium Sulfate Versus Indomethacin for Preterm LaborTerminatedNCT00116623Phase 4
• Pain Relief - Tramadol Versus IbuprofenStatus unknownNCT00111046Phase 1/2
• Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialCompletedNCT00110448Phase 4
• Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee OsteoarthritisCompletedNCT00108992Phase 3
• Celecoxib Treatment for Lung CancerWithdrawnNCT00108186Phase 1
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
• Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00104767Phase 1
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedNCT00101335Phase 2
• Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerTerminatedNCT00101062Phase 2
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)CompletedNCT00092781Phase 3
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)CompletedNCT00092768Phase 3
• An Investigational Drug in Patients With Osteoarthritis (0663-073)CompletedNCT00092755Phase 3
• Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)CompletedNCT00092742Phase 3
• An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)CompletedNCT00092729Phase 3
• Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)CompletedNCT00092703Phase 3
• A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)CompletedNCT00092378Phase 3
• A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)CompletedNCT00092365Phase 3
• A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)CompletedNCT00092352Phase 3
• A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)CompletedNCT00092339Phase 3
• A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)CompletedNCT00092326Phase 3
• A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)CompletedNCT00092300Phase 3
• Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00088959Phase 1
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNCT00085826Phase 3
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00084448Phase 2
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic OophorectomyWithdrawnNCT00084370Not applicable
• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumTerminatedNCT00081224Phase 2
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesTerminatedNCT00080782Phase 2
• Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerCompletedNCT00078910Phase 2
• Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast CancerTerminatedNCT00075673Phase 1
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNCT00073970Phase 2
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
• Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00072618Phase 1/2
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
• S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the CervixWithdrawnNCT00072540Phase 2
• Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
• Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerCompletedNCT00070057Phase 1
• Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00068653Phase 2
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Aggrenox Prevention of Access StenosisCompletedNCT00067119Phase 3
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2

← Cyclooxygenase Inhibitors overview